Da. Cox et Ml. Cohen, RELATIONSHIP BETWEEN PHOSPHOLIPASE-D ACTIVATION AND ENDOTHELIAL VASOMOTOR DYSFUNCTION IN RABBIT AORTA, The Journal of pharmacology and experimental therapeutics, 283(1), 1997, pp. 305-311
Lysophosphatidylcholine (lysoPC) causes endothelial vasomotor dysfunct
ion in isolated blood vessels, although the signaling pathways involve
d in this effect remain to be established. Although lysoPC stimulated
phospholipase D (PLD) activity in cultured endothelial cells, the role
of PLD in the vascular effects of lysoPC remains unclear. This study
investigated the hypothesis that PLD is involved in lysoPC-induced end
othelial vasomotor dysfunction in isolated rabbit aorta. LysoPC (3-30
mu M) stimulated vascular PLD activity and inhibited endothelium-depen
dent vasorelaxation to acetylcholine within an identical concentration
range. In contrast, lysoPC-induced inhibition of vasorelaxation was n
ot prevented by the selective protein kinase C (PKC) inhibitor, GF1092
03X (3 mu M), which suggested that this enzyme was not involved in the
endothelial vasomotor dysfunction produced by lysoPC. The ability of
two other lysophospholipids, lyso-platelet-activating factor (3-30 mu
M) and lysophosphatidylserine (10-30 mu M) to induce endothelial vasom
otor dysfunction was also associated closely with their ability to sti
mulate vascular PLD activity. Parallel stimulation of PLD activity and
inhibition of acetylcholine-induced relaxation was also observed with
orthovanadate (0.1-3 mM), which suggested that the association betwee
n PLD activation and endothelial vasomotor dysfunction was not a pheno
menon particular to lysophospholipids. The magnitude of PLD stimulatio
n and the extent of endothelial dysfunction induced by these diverse s
timuli were highly correlated (r(2) = 0.88). These observations sugges
t that the PLD signal transduction pathway is important in the endothe
lial vasomotor dysfunction produced by lysophospholipids and perhaps o
ther agents.